Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection

PHASE1UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

February 1, 2024

Conditions
Long COVID
Interventions
PROCEDURE

Adipose Tissue Harvest

"Local Anesthesia will be administered. A Stab wound will be created at the harvest site through which a 3.0 or 2.5 mm cannula will be inserted to suction fat using the syringe (i.e. manual) technique. A total of 100 cc of lipoaspirate will be collected by manual draw of the adipose tissue into syringes."

BIOLOGICAL

ATCell

Infusion of the study medication at the rate of 575 mL/HR (500ml of LRD5 plus 75ml of ATCell suspended in LRD5) and continue until all received trial medication has been delivered.

Sponsors
All Listed Sponsors
lead

American CryoStem Corporation

INDUSTRY

NCT05669261 - Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection | Biotech Hunter | Biotech Hunter